Related to Altravax Awarded $3.45M from NIAID for HIV-1 Vaccine Research

• Sanofi Pasteur Pays Vivalis €3M for Access to Human mAb Platform for Infectious Diseases
  
• IncellDx to Start U.S. Clinical Trials of HPV Test with $3M Financing
  
• DSM to Manufacture Novacta’s C. Difficile Compound for Preclinical and Phase I Studies
  
• Investigators Describe How Bacteria Form Syringe-Like Structure that Helps Infection
  
• FDA Partially Lifts Clinical Hold on Merck Serono’s Anticancer Vaccine
  
• BD Applies Exiqon Technology to Infectious Disease Diagnostics
  
• FDA Sanctions Abbott’s Test that Detects HIV Antigen and Antibodies
  
• Texas Cancer Prevention Organization Awards Rice University $3.7M for Cancer Diagnostic Bio-Nano-Chip
  
• Nonprofit Organizations Join Forces to Evaluate Adjuvants for Pandemic Flu Vaccines
  
• Scancell and Immatics to Explore Combination of Vaccine Technologies for Colorectal Cancer
  
• Emergent Wins $107M Contract to Triple Anthrax Vaccine Production
  
• Cytos and Life Technologies Partner with A*Star in Separate Deals
  
• Pivotal Trials Show Tibotec's HIV Drug Halves Rate of Treatment Withdrawal
  
• Immune Design Scores $32M in Series B Financing
  
• Isis Earns $5M Milestone from GSK Five Months into RNA Therapeutics Partnership
  
• FDA Green-Lights Thermo Fisher Scientific’s VRE Diagnostic
  
• PPD Expands cGMP Lab Services in North America
  
• Swiss TPH to Evaluate Telormedix’ Adjuvant for Malaria and Buruli Ulcer Immunization
  
• Mayo Clinic to Evaluate TapImmune’s TAP Tech with Smallpox Vaccine
  
• Medicago Wins $21M DARPA Award to Scale Up Production of Flu Vaccines